¹Ú»ç´Ô Q&A
À¯¹æ¾Ï°ú °ü·ÃµÈ ±Ã±ÝÇÑ Á¡ÀÌ ÀÖÀ¸½Ã¸é ±ÛÀ» ³²°ÜÁÖ¼¼¿ä.
¹Ú»ç´Ô Q&A
À¯¹æ°ü·Ã °¢Á¾ Áúȯ¿¡ ´ëÇØ ±Ã±ÝÇÑ Á¡ÀÌ ÀÖÀ¸½Ã¸é ±ÛÀ» ³²°ÜÁÖ¼¼¿ä. Á¤½ÂÇÊ ¹Ú»ç´ÔÀÌ Ä£ÀýÇÑ »ó´ãÀ» ÇØ µå¸³´Ï´Ù.
´äº¯Ç׾Ͽ©ºÎ
ÀÛ¼ºÀÚ : Á¤½ÂÇÊ ÀÛ¼ºÀÏ : 2022-10-03 [16:04]Á¶È¸ : 2,310
¼±Áö¿¬´Ô²²

¸ÕÀú, ¼ö¼ú°á°ú¿¡ ´ëÇØ °¡Àå Àß ¾Ë°í °è½Ã´Â ºÐÀº ´ã´ç ¼±»ý´Ô À̽ʴϴÙ.
ÀÇ·ÚÇϽŠ¿ÂÄÚŸÀÔDx °á°ú ³ª¿Â´ë Àß µû¸£½Ã±â ¹Ù¶ø´Ï´Ù.

¹æ»ç¼±Ä¡·á·Î ÀÎÇÑ 2Â÷ Áúº´ÀÇ °¡´É¼ºÀÌ ÀÖÀ¸³ª ±× °¡´É¼ºÀÌ ¸Å¿ì ³·°í, À¯¹æ¾Ï Àç¹ß °¡´É¼ºÀ» ³·Ãß´Â È¿°ú°¡ ¿ùµîÇϱ⠶§¹®¿¡ ¸ðµç À¯¹æ º¸Á¸¼ú ȯÀÚ´Â ¹æ»ç¼±Ä¡·á¸¦ ¹Þ´Â °ÍÀÌ ¾ÈÀüÇÕ´Ï´Ù.

5³â ÀÌÈÄ Àç¹ßÀ̳ª ÀüÀ̵îÀº ¾Æ¸¶µµ Ãʱ⿡ ÀÖ´ø À¯¹æ¾Ï¼¼Æ÷µéÀÌ ¸ö ¾îµò°¡¿¡ ¼û¾îÀÖ´Ù°¡ ¾î¶² ÀÌÀ¯·Î ´Ù½Ã È°¼ºÀÌ µÇ¾î Àç¹ßÀ̳ª ÀüÀ̸¦ ÀÏÀ¸Å°´Â °ÍÀ¸·Î »ý°¢Çϱ⠶§¹®¿¡ ±× °¡´É¼ºÀ» ³·Ãß±â À§ÇØ ¹æ»ç¼±Ä¡·á, Ç×¾ÏÄ¡·á, Ç×È£¸£¸óÄ¡·áµîÀÇ º¸Á¶ Ä¡·á¸¦ ½ÃÇàÇÏ´Â °ÍÀÔ´Ï´Ù.
µû¶ó¼­ Èûµå½Ã´õ¶ó°í ´ã´ç ¼±»ý´ÔÀÌ ±ÇÇÏ´Â Ä¡·á Àß ¹Þ°í °Ç°­È¸º¹ÇϽñ⠱â¿øÇÕ´Ï´Ù.

Á¤½ÂÇÊ µå¸²



¼±Áö¿¬ ´Ô ¿ø¹®³»¿ë

Ç׾Ͽ©ºÎ

¿¡½ºÆ®·Î°Õ 90%
ÇÁ·Î°Ô½ºÅ×·Ð 90%
P53 positive in <25%
ÇãÅõ negative (+/3)((++/3)<10%)
Ki67 positive in 3%
Cytokeratin 5-6 negative
Androgen receptor positive in 90%

Invasive tumor size 0 6¡¿0 3¡¿1.1
Tumor extent including DCIS 1.1 ¡¿0.4¡¿2.0
Nuclear grade 2/3
Histology grade 2/3
in situ component DCIS present moderate in and around the Tumor non commodore type intermediate grade
Tumor border infiltrative
¹Ì¼¼¼®È¸ ¾øÀ½
¸²ÇÁ°üÀüÀÌ Ç÷°üÀüÀÌ ¾øÀ½
°¡ÀåÀÚ¸® ±ú²ý
¸²ÇÁÀýÁ¦°Å 8°³

¹Ú»ç´Ô
Ç×¾ÏÆнºÇÒÁپ˾Ҵµ¥ ¿ÂÄÚ°Ë»çÀÇ·ÚÇß½À´Ï´Ù
°á°ú°¡ ¾î¶»µç Ç×¾ÏÀº ¾ÈÇÏ°í ½Í½À´Ï´Ù
¿äÁòµå´Â»ý°¢ÀÌ ¹æ»ç¼±µµ ²À ÇؾßÇϳª Àǹ®ÀÔ´Ï´Ù
¹æ»ç¼±ÀÌ ´Ù¸¥¾ÏÀ» À¯¹ßÇÑ´Ù´Â ¿¬±¸°á°úµµ ÀÖ°í
¹æ»ç¼±Ä¡·á°¡ ÀüÀÌ Àç¹ßÀ» ³ôÈù´Ù´Â ÀÇ°ßµµ À־
°í¹ÎÁßÀÔ´Ï´Ù
¹æ»ç¼±Ä¡·á ²À ÇؾßÇÒ±î¿ä

À¯¹æ¾ÏÀÇ °æ¿ì 5³âÁö³ª Àç¹ß ÀüÀ̵Ǵ »ç·ÊµéÀÌ ¸¹Àºµ¥ ÀÌ·±°ÍµéÀÇ ¿øÀÎÀÌ ¹«¾ùÀϱî¿ä
¿äÁò Á¦°¡ ÀÐÀºÃ¥µé¿¡¼­´Â Ç×¾ÏÁ¦³ª ¹æ»ç¼±ÀÇ ¿øÀÎÀ¸·Î º¸´Â°ßÇØ°¡ ÀÖ¾î ¹Ú»ç´Ô ÀÇ°ßÀÌ ±Ã±ÝÇÕ´Ï´Ù
¼öÁ¤»èÁ¦´äº¯ÀÛ¼º¸ñ·Ï
¹øÈ£
Á¦¸ñ
ÀÛ¼ºÀÚ
ÀÛ¼ºÀÏ
Á¶È¸
°øÁö Q&A´Â À½½Ä ¹× ½ÄÇ°¿¡ ´ëÇÑ ´äº¯À» µå¸®Áö ¾Ê½À´Ï´Ù.
°øÁö Á¤½ÂÇʱ³¼ö´Ô º¸°Çº¹ÁöºÎÀå°ü»ó ¼ö»ó ¼Ò½Ä
°øÁö À¯¹æ¾Ï Ä¡·á ¼ö½Êȸ À̱ä 'Ä£Á¤¾ö¸¶' °ûÁ¡¼ø ȸÀå "5³â¸¸ ´Þ·¨´Âµ¥ ÀÌ·ðÀ¸´Ï Æò»ý ºÀ»çÇؾßÁö"
°øÁö Çѱ¹À¯¹æ¾Ïȯ¿ìÃÑ¿¬ÇÕȸ: ¿£ÇãÅõ ±Þ¿©¸¦ Ã˱¸ÇÏ´Â Àü±¹¹Î ¼­¸í¿îµ¿À» ½ÃÀÛÇÕ´Ï´Ù
5404
¾È³çÇϼ¼¿ä ¹Ú»ç´Ô
Á¤½ÂÇÊ 2023-05-09 1,163
5403
À¯¹æ¾Ï11³âÂ÷Àε¥ ¹Ý´ëÂÊ ÃÊÀ½ÆÄ C4b..
À¯Áø 2023-04-11 1,619
5402
À¯¹æ¾Ï11³âÂ÷Àε¥ ¹Ý´ëÂÊ ÃÊÀ½ÆÄ C4b..
Á¤½ÂÇÊ 2023-04-12 1,583
5401
À¯¹æ¾Ï ¼ö¼úÈÄ ÀÓ½Å
Á¶¼­Á¤ 2023-04-06 974
5400
À¯¹æ¾Ï ¼ö¼úÈÄ ÀÓ½Å
Á¶¼­Á¤ 2023-04-15 793
5399
À¯¹æ¾Ï ¼ö¼úÈÄ ÀÓ½Å
Á¤½ÂÇÊ 2023-04-12 739
5398
°Ë»ç°£°Ý
ÃÖÀμ÷ 2023-03-17 1,040
5397
°Ë»ç°£°Ý
Á¤½ÂÇÊ 2023-03-19 947
5396
    °Ë»ç°£°Ý
ÃÖÀμ÷ 2023-03-19 893
5395
Ç×¾ÏÄ¡·áÁß¿¡ È­Àå½Ç ÇÔ²²Çصµ
ÇýÁ¤ 2023-01-24 1,456
5394
Ç×¾ÏÄ¡·áÁß¿¡ È­Àå½Ç ÇÔ²²Çصµ
Á¤½ÂÇÊ 2023-01-26 1,411
5393
2023³â °è¹¦³â »õÇØÀλç
ÇÑÀ¯ÃÑȸ 2023-01-02 1,483
5392
¼ö¼ú ¹ÞÀºÂÊ ÆÈ¿¡ ÇÇ »Ì´Â°Ç ¾ðÁ¦±îÁö ¾ÈÇØ¾ß ÇÏ´ÂÁö¿À
±Ã±ÝÀÌ 2022-10-06 2,616
5391
¼ö¼ú ¹ÞÀºÂÊ ÆÈ¿¡ ÇÇ »Ì´Â°Ç ¾ðÁ¦±îÁö ¾ÈÇØ¾ß ÇÏ´ÂÁö¿À
Á¤½ÂÇÊ 2022-10-10 2,717
5390
    ¼ö¼ú ¹ÞÀºÂÊ ÆÈ¿¡ ÇÇ »Ì´Â°Ç ¾ðÁ¦±îÁö ¾ÈÇØ¾ß ÇÏ´ÂÁö¿À
±Ã±ÝÀÌ 2022-10-10 2,238
5389
Ç׾Ͽ©ºÎ
¼±Áö¿¬ 2022-09-18 2,539
5388
Ç׾Ͽ©ºÎ
Á¤½ÂÇÊ 2022-10-03 2,310
5387
¹®Àǵ帳´Ï´Ù.
Èñ¸Á 2022-07-22 2,752
12345678910+10¸¶Áö¸·
 
ÀÛ¼º¸ñ·Ï